December 10th – 14th, 2019

The San Antonio Breast Cancer Symposium

TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)

  View Poster

September 27th – October 1st, 2019

ESMO, Barcelona

TRYbeCA-2: A Randomized Phase 2/3 Study of Eryaspase in Combination with Gemcitabine and Carboplatin Chemotherapy versus Chemotherapy Alone As First-Line Treatment in Patients with Metastatic or Locally Recurrent Triple-Negative Breast Cancer (NCT03674242)

  View Poster

September 6th – 9th, 2019

AACR pancreatic meeting, Boston

TRYbeCA-1: A Randomized, Phase 3 Study of Eryaspase in CombinaBon with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in PaBents with PancreaBc Adenocarcinoma (NCT03665441)

  View Poster

July 4th, 2019

ESMO World Congress on Gastrointestinal Cancer 2019

Abstract P-098: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

  View Poster

April 1st, 2019

AACR – American Association for Cancer Research

Erymethionase (methionine-γ-lyase encapsulated into red blood cells)
potentiates anti-PD1 therapy in TNBC-like syngeneic mouse model

  View Poster

March 11, 2019

ERCS European Red Cell Research Society 22nd Meeting

Comprehensive proteomic profiling of erythrocytes following hypotonic dialysis-based drug encapsulation process

  View Poster

January 17-19, 2019

Gastrointestinal Cancers Symposium (ASCO-GI)

Abstract TPS471: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441).

  View Poster

June 14-17, 2018

European Hematology Association (EHA) Congress

Preclinical Demonstration of Intracellular Activity of Asparaginase Encapsulated in Red Blood Cells Both in the Absence and in the Presence of Neutralizing Anti-Asparaginase Antibodies

Date/Time: Friday, June 15, 2018 / 5:30 p.m. – 7:00 p.m. (CEST)

  View Poster

A Phase 2b of Eryaspase in Combination with Low-Dose Cytarabine as First-Line Therapy in Elderly Patients with Acute Myeloid Leukemia (ENFORCE – NCT01810705)

Date/Time: Saturday, June 16, 2018 / 5:30 p.m. – 7:00 p.m. (CEST)

  View Poster

Venous Thromboembolism in Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Eryaspase (L-Asparaginase Encapsulated in Red Blood Cells)

  View Abstract

June 1-5, 2018

American Society of Cancer Oncology (ASCO)

Pharmacodynamic Characterization of eryaspase (L-asparaginase Encapsulated in Red Blood Cells) in Combination with Chemotherapy in a Phase 2/3 Trial in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517).

Date/Time: June 4, 2018 / 8:00 a.m. – 11:30 a.m

  View Poster

April 14-18, 2018

American Association for Cancer Research (AACR)

A Phase 1 Study Of Eryaspase (L-Asparaginase Encapsulated In Red Blood Cells) In Combination With Induction And Consolidation Chemotherapy For Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) (NCT01910428)

Date/Time: April 15th, 2018

  View Poster

Enzymatic combination investigation in cancer therapy

Date/Time: April 18th, 2018

  View Poster

September 8-12th, 2017

European Society for Medical Oncology (ESMO)

A Phase 2b of eryaspase in combination with gemcitabine or FOLFOX as second-line therapy in patients with metastatic pancreatic adenocarcinoma (NCT02195180)

Date/Time: September 8-11th,2017

  View Poster

Erytech Investor & Analyst Event at ESMO

Date/Time: September 11th, 2017 

  Click Here for Webcast (available until December 10, 2017) and click here for Slide Presentation

September 5-8th, 2017

13th International Congress of Inborn Errors of Metabolism (ICIEM)

Eryminase, Arginine Deiminase-Encapsulated in Red Blood Cells Effectively Lower Blood Arginine Levels in a Mouse Model of Inducible Hyperargininemia

Date/Time: September 6th, 2017/ 5:30-8:00PM BRT

  View Poster

Erymethionase, Methioninase Entrapped in Red Blood Cells: an innovative treatment approach for classical homocystinuria

Date/Time: September 6th, 2017/ 5:30-8:00PM BRT

  View Poster

April 1-5, 2017

American Association for Cancer Research (AACR) Annual Meeting

Use of methionine gamma-lyase-loaded erythrocytes to induce effective methionine depletion of cancer therapy

Date/Time: April 3, 2017/1:00-5:00 PM EDT

  View Poster

January 19-21, 2017

2017 Gastrointestinal Cancers Symposium (ASCO GI)

Methionine gamma-lyase-encapsulated into red blood cells (ERY-MET) shows profound antitumor activity in gastric carcinoma

Date/Time: January 19, 2017/12:30-2PM PST, 5:30-7PM PST

  View Poster

Menu